Topics
CME/CE
Editorial Board
Bexarotene Therapy
Chicago - Results of two clinical trials involving bexarotene (Targretin) and presented at recent meetings of the American Academy of Dermatology offer hope for patients with severe forms of psoriasis refractory to systemic therapies, according to researchers.
Related Videos
Related Content
